World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
122
Citations
82647
World Ranking
3405
National Ranking
1875

Research.com Recognitions

  • 1991 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

John Crowley is affiliated with Washington University in St. Louis in the United States and has focused much of their research within the field of Medicine. Their main areas of study include Pulmonary and Respiratory Medicine, Surgery, Rheumatology, Oncology, and Genetics. The scientist's academic contributions span various topics, notably in Lung Cancer Treatments and Mutations, Statistical Methods in Clinical Trials, Bone Tumor Diagnosis and Treatments, Sarcoma Diagnosis and Treatment, Musculoskeletal synovial abnormalities and treatments, Dementia and Cognitive Impairment Research, as well as Health disparities and outcomes.

The scientist has published in several frequent venues, including:

  • Journal of Crohn s and Colitis
  • UNC Libraries
  • Skeletal Radiology
  • The Journal of Prevention of Alzheimer s Disease
  • Journal of Vascular and Interventional Radiology

Several recent papers highlight their contributions to medical research, including:

  • Percutaneous thermal ablation for treatment of osteoid osteoma: a systematic review and analysis (2020), published in Skeletal Radiology
  • Mental Component Score (MCS) from Health-Related Quality of Life Predicts Incidence of Dementia in U.S. Males (2021), published in The Journal of Prevention of Alzheimer s Disease
  • Society of Interventional Radiology Quality Improvement Standards for Percutaneous Nephrostomy in the Pediatric Population (2020), published in Journal of Vascular and Interventional Radiology
  • Adjuvant chemotherapy for stage IA-IIA non-squamous, non-small-cell lung cancer identified as molecular high-risk by a 14-gene expression profile (AIM-HIGH): an international, randomised, phase 3 trial (2025), published in The Lancet Respiratory Medicine
  • DOP64 Steroid-sparing effect of risankizumab vs ustekinumab in patients with moderately to severely active Crohn's Disease: Post hoc results from the phase 3b SEQUENCE trial (2024), published in Journal of Crohn s and Colitis

Crowley has collaborated frequently with other researchers, including:

  • David R. Gandara
  • Will S. Lindquester
  • C. Matthew Hawkins
  • Xiuhua Ding
  • Erin L. Abner

In recognition of their scientific contributions, John Crowley received the title of Fellow of the American Association for the Advancement of Science (AAAS) in 1991.

Best Publications

  • The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer.

    Peter Goldstraw;Kari Chansky;John Crowley;Ramon Rami-Porta

  • The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.

    Peter Goldstraw;John Crowley;Kari Chansky;Dorothy J. Giroux

  • International staging system for multiple myeloma.

    Philip R. Greipp;Jesus San Miguel;Brian G.M. Durie;John J. Crowley

  • The Influence of Finasteride on the Development of Prostate Cancer

    Ian M. Thompson;Phyllis J. Goodman;Catherine M. Tangen;M. Scott Lucia

  • Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter

    Ian M. Thompson;Donna K. Pauler;Phyllis J. Goodman;Catherine M. Tangen

  • International uniform response criteria for multiple myeloma

    B. G. M. Durie;J.-L. Harousseau;J. S. Miguel;J. Blade

  • Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

    Scott M. Lippman;Eric A. Klein;Eric A. Klein;Phyllis J. Goodman;M. Scott Lucia

  • Underrepresentation of patients 65 years of age or older in cancer-treatment trials.

    Laura F. Hutchins;Joseph M. Unger;John J. Crowley;Charles A. Coltman

  • Vitamin E and the Risk of Prostate Cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)

    Eric A. Klein;Ian M. Thompson;Catherine M. Tangen;John J. Crowley

  • The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer

    Ramón Rami-Porta;David Ball;John Crowley;Dorothy J. Giroux

  • Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033

    Charles D. Blanke;Cathryn Rankin;George D. Demetri;Christopher W. Ryan

  • National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.

    Eifel P;Axelson Ja;Costa J;Crowley J

  • The molecular classification of multiple myeloma

    Fenghuang Zhan;Yongsheng Huang;Yongsheng Huang;Simona Colla;Simona Colla;James P. Stewart;James P. Stewart

  • Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805.

    Kathy S. Albain;Valerie W. Rusch;John J. Crowley;Thomas W. Rice

  • Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial

    Hussein A Tawbi;Melissa Burgess;Vanessa Bolejack;Brian A Van Tine

  • A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1

    John D. Shaughnessy;Fenghuang Zhan;Bart E. Burington;Yongsheng Huang

  • Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience.

    Kathy S. Albain;John J. Crowley;Michael LeBlanc;Robert B. Livingston

  • Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

    S. K. Kumar;J. H. Lee;J. J. Lahuerta;G. Morgan

  • A Confidence Interval for the Median Survival Time

    Ron Brookmeyer;John Crowley

  • Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower.

    Ian M. Thompson;Donna Pauler Ankerst;Chen Chi;M. Scott Lucia

Frequent Co-Authors

Bart Barlogie
Bart Barlogie Mount Sinai Hospital
Frits van Rhee
Frits van Rhee University of Arkansas for Medical Sciences
John D. Shaughnessy
John D. Shaughnessy University of Arkansas for Medical Sciences
David R. Gandara
David R. Gandara University of California, Davis
Joshua Epstein
Joshua Epstein University of Arkansas for Medical Sciences
Elias Anaissie
Elias Anaissie University of Cincinnati
Maurizio Zangari
Maurizio Zangari University of Arkansas for Medical Sciences
Brian G.M. Durie
Brian G.M. Durie Cedars-Sinai Medical Center
Saad Z. Usmani
Saad Z. Usmani Memorial Sloan Kettering Cancer Center
Robert B. Livingston
Robert B. Livingston University of Arizona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in flexible routes into medical professions, there are various online degree options to consider. Many accelerated MSN to DNP programs offer a streamlined path for nurses aiming to achieve a Doctor of Nursing Practice degree faster, which can be a significant advantage for career advancement.

Cost can be a barrier, so looking for the cheapest DNP programs can help reduce financial stress while maintaining educational quality. Students seeking the most efficient path may want to explore fast track medical programs, which are designed to allow entry into the healthcare workforce quickly.

Specialization is also possible with online degrees. For example, there are accelerated MSN psychiatric NP programs that prepare nurses for in-demand mental health specialties in less time. If you’re a working nurse, research the variety of accelerated MSN to DNP programs available to find one that fits your goals and schedule.

Best Scientists Citing John Crowley

Trending Scientists